Drugs / ALK Alutard SQ 5-grasses
last change Jun 2022 re-read 3 minutes ago

ALK Alutard SQ 5-grasses

Developed for
seasonal allergic rhinitis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2/3 NCT02975479 Comparator May 2016 → Jun 2022 seasonal allergic rhinitis Karolinska Institutet Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ALK Alutard SQ 5-grasses ClinicalTrials.gov intervention name — accepted as the source's own label NCT02975479 ↗
Route Other “intralymphatic injections” NCT02975479 ↗